Source: Annual Congress 2013 –COPD: experimental biology
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. G. Guney, R. Holloway, A. Taylor, C. Thomas, P. Barnes, L. Donnelly (London, United Kingdom). Increased expression of sphingosine-1-phosphate and S1PR2 are associated with attenuated macrophage phagocytosis in COPD. Eur Respir J 2013; 42: Suppl. 57, 626

Member's Comments

No comment yet.

Related content which might interest you: Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages Source: International Congress 2016 – Mechanisms of disease Year: 2016 Impaired monocyte chemotaxis in COPD Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Increased susceptibility of M2 monocyte-derived macrophages from COPD patients to oxidative stress Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Effect of JQ-1 on monocyte-derived macrophage (MDM) phagocytosis of bacteria and cytokine release Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Distinct localization of estrogen receptors in lungs of severe COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 IL32 expression in induced sputum of COPD subjects Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Characterization of M1 and M2 macrophages in human lung tissue Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Elevated GM-CSF in COPD may drive defective macrophage phenotype Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Monocyte sub-populations do not reflect differences in COPD macrophage phenotype Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 NDP52 inhibition rescues cigarette smoke mediated impairment of autophagy in macrophages Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Oxidative stress drives defective efferocytosis in COPD M2-like macrophages Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Macrophage phenotype does not affect protease anti-protease imbalance in COPD Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Identification of Ki67+ ’monocytic’ cells within the lungs Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 The effect of in vitro culture methods on corticosteroid sensitivity in COPD alveolar macrophages Source: Annual Congress 2013 –COPD: experimental biology Year: 2013